1 | 111JC101 | - | - | - | - | 1件: 25 25 |
2 | CE-VST01-JC | 1件: CE-VST01-JC CE-VST01-JC | - | - | - | 1件: 25 25 |
3 | Cidofovir | 1件: Cidofovir Cidofovir | 1件: D00273
D00273
| - | - | 1件: 25 25 |
4 | Collection of blood and urine | - | - | - | - | 1件: 25 25 |
5 | CYT107 | - | - | - | - | 1件: 25 25 |
6 | Cytarabine | 1件: Cytarabine Cytarabine | 1件: D00168
D00168
| - | - | 7件: 11 11, 13, 14, 25, 49, 60, 65 |
7 | Didanosine | 1件: Didanosine Didanosine | 1件: D00296
D00296
| - | - | 2件: 25 25, 265 |
8 | Emtricitabine | 1件: Emtricitabine Emtricitabine | 1件: D01199
D01199
| - | - | 4件: 25 25, 93, 265, 325 |
9 | Enfuvirtide | 1件: Enfuvirtide Enfuvirtide | 1件: D02499
D02499
| - | - | 2件: 25 25, 265 |
10 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 28件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
11 | Interferon alfa | 1件: Interferon alfa Interferon alfa | 1件: D03305
D03305
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 5件: 25 25, 26, 28, 56, 96 |
12 | Interferon alfa-2b | 2件: Interferon alfa Interferon alfa, Interferon alfa-2b | 2件: D02745
D02745
,
D03305
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 25 25 |
13 | Interleukin-7 | 1件: Interleukin-7 Interleukin-7 | - | - | - | 1件: 25 25 |
14 | Lariam | 1件: Mefloquine Mefloquine | 1件: D04895
D04895
| - | - | 1件: 25 25 |
15 | MEFLOQUINE | 1件: Mefloquine Mefloquine | 1件: D04895
D04895
| - | - | 2件: 25 25, 46 |
16 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
17 | NATALIZUMAB | 1件: Natalizumab Natalizumab | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 5件: 13 13, 15, 25, 46, 96 |
18 | Neurological evaluation | - | - | - | - | 1件: 25 25 |
19 | NT-I7 | 1件: Efineptakin alfa Efineptakin alfa | 1件: D11957
D11957
| - | - | 1件: 25 25 |
20 | Pembrolizumab | 1件: Pembrolizumab Pembrolizumab | 1件: D10574
D10574
| 1件: PDCD1 PDCD1 💬 | 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 25 25, 285 |
21 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
22 | Probenecid | 1件: Probenecid Probenecid | 1件: D00475
D00475
| - | - | 1件: 25 25 |
23 | PyVST | - | - | - | - | 1件: 25 25 |
24 | Recombinant human interleukin-7 | 1件: Interleukin-7 Interleukin-7 | - | - | - | 1件: 25 25 |
25 | Spinal tap | - | - | - | - | 1件: 25 25 |
26 | Tenofovir | 1件: Tenofovir disoproxil Tenofovir disoproxil | - | - | - | 6件: 2 2, 13, 25, 93, 265, 325 |
27 | Tenofovir-Emtricitabine | 2件: Emtricitabine Emtricitabine, Tenofovir | 2件: D01199
D01199
,
D06074
| - | - | 1件: 25 25 |
28 | TERIFLUNOMIDE | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 3件: 13 13, 25, 26 |
29 | Topotecan | 1件: Topotecan Topotecan | 1件: D08618
D08618
| 1件: TOP1 TOP1 💬 | - | 1件: 25 25 |
30 | TYSABRI | 1件: Natalizumab Natalizumab | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 3件: 13 13, 25, 63 |
31 | Zalcitabine | 1件: Zalcitabine Zalcitabine | 1件: D00412
D00412
| - | - | 1件: 25 25 |
32 | Zidovudine | 1件: Zidovudine Zidovudine | 1件: D00413
D00413
| - | - | 6件: 25 25, 26, 135, 265, 325, 331 |